Sarcopenia is age-related loss of skeletal muscle mass and function, leading to physical disability, poor quality of life and eventually death. Sarcopenia negatively impacts many seniors, and can lead to loss of mobility, increased risk of falls and an associated loss of independence.  Whilst the incidence and societal cost of sarcopenia are well understood, there are currently no therapeutics approved to treat this debilitating condition. Imitex’s approach, based on a detailed understanding of the molecular processes that drive muscle strengthening, offer new solutions to this condition.